Armata Pharmaceuticals, INC. (ARMP) — 10-K Filings

All 10-K filings from Armata Pharmaceuticals, INC.. Browse 3 Annual Report reports with AI-powered summaries and risk analysis.

10-K Filings (3)

Armata's Phage Therapy Shows Promise in Lung Infections — Mar 25, 2026 Risk: high
Armata Pharmaceuticals, Inc. (ARMP) is a late clinical-stage biotechnology company focused on developing bacteriophage therapeutics for antibiotic-resistant bac
Armata Pharmaceuticals Files 2024 10-K — Mar 21, 2025 Risk: medium
Armata Pharmaceuticals, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly AmpliPhi Biosciences Corp, is based in Los Angel
Armata Pharmaceuticals Files 2023 Annual Report on Form 10-K — Mar 21, 2024 Risk: low
Armata Pharmaceuticals, Inc. (ARMP) filed a Annual Report (10-K) with the SEC on March 21, 2024. Armata Pharmaceuticals, Inc. filed its annual report on Form 10

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX